New diabetes clinical trial: Impaired Glucose Tolerance in Vietnamese Infertile PCOS Women | | |
New diabetes clinical trial: Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet | | |
New diabetes clinical trial: Is Fat in the Liver a Marker of Post-Pregnancy Glycaemic Deterioration in Women With Gestational Diabetes? | | |
New diabetes clinical trial: Identification of β Cell Dysfunction in Relatives of Individuals With Type 1 Diabetes Mellitus | | |
New diabetes clinical trial: A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. | | |
New diabetes clinical trial: The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients | | |
New diabetes clinical trial: TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients | | |
New diabetes clinical trial: Effect of Walking on Sand With Dietary Intervention in Overweight Type 2 Diabetes Mellitus Patients: A Randomized Controlled Trial. | | |
New diabetes clinical trial: Pre- and Postoperative Probiotics Administration in Patients Undergoing Sleeve Gastrectomy | | |
New diabetes clinical trial: Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss | | |
New diabetes clinical trial: Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic | | |
New diabetes clinical trial: Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers | | |
New diabetes clinical trial: Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform | | |
New diabetes clinical trial: Nutrition Product Combine With Continuous Glucose Monitoring in Gestational Diabetes Mellitus Patients | | Published on: April 30, 2020 at 07:00PM Conditions: SANZ®KINGWILL Combined With CGM Equipment in GDM Patients; GLUCERNA SR® Combined With CGM Equipment in GDM Patients Interventions: Dietary Supplement: SANZ®KINGWILL; Dietary Supplement: GLUCERNA SR® Sponsors: Peking Union Medical College Hospital; San MediTech(Huzhou)Co.,Ltd.; Sanz Pharmaceutical Group; Beijing Chao Yang Hospital; Beijing Obstetrics and Gynecology Hospital Recruiting https://clinicaltrials.gov/ct2/show/NCT04368741?term=diabetes&sfpd_d=14 April 30, 2020 at 02:49PM via ClinicalTrials.gov |
New diabetes clinical trial: Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery | | |
New diabetes clinical trial: Program ACTIVE: Phase 2 | | |
New diabetes clinical trial: CHOlesterol Lowering and Residual Risk in Type 2 Diabetes | | |
New diabetes clinical trial: Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes | | |
Няма коментари:
Публикуване на коментар